Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.59
-3.66 (-3.57%)
Aug 20, 2026, 10:48 AM EDT - Market open
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 433 employees as of June 30, 2026. The number of employees increased by 84 or 24.07% compared to the same quarter last year.
Employees
433
Change
84
Growth
24.07%
Revenue / Employee
$1,427,406
Profits / Employee
-$1,986,621
Market Cap
6.40B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 433 | 84 | 24.07% | 433 | 0 |
| Mar 31, 2026 | 418 | 84 | 25.15% | 418 | 0 |
| Dec 31, 2025 | 372 | 50 | 15.53% | 369 | 3 |
| Sep 30, 2025 | 355 | 44 | 14.15% | 355 | 0 |
| Jun 30, 2025 | 349 | 55 | 18.71% | 349 | 0 |
| Mar 31, 2025 | 334 | 56 | 20.14% | 334 | 0 |
| Dec 31, 2024 | 322 | 58 | 21.97% | 322 | 0 |
| Sep 30, 2024 | 311 | 62 | 24.90% | 311 | 0 |
| Jun 30, 2024 | 294 | 81 | 38.03% | 294 | 0 |
| Mar 31, 2024 | 278 | 78 | 39.00% | 278 | 0 |
| Dec 31, 2023 | 264 | 68 | 34.69% | 264 | 0 |
| Sep 30, 2023 | 249 | 55 | 28.35% | 249 | 0 |
| Jun 30, 2023 | 213 | 42 | 24.56% | 213 | 0 |
| Mar 31, 2023 | 200 | 56 | 38.89% | 200 | 0 |
| Dec 31, 2022 | 196 | 59 | 43.07% | 196 | 0 |
| Sep 30, 2022 | 194 | 57 | 41.61% | 194 | 0 |
| Jun 30, 2022 | 171 | 51 | 42.50% | 171 | 0 |
| Mar 31, 2022 | 144 | 59 | 69.41% | 144 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| TG Therapeutics | 399 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
MIRM News
- 8 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 13 days ago - Mirum sinks after FDA recommends conducing Phase 3 study - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $140 from $145 at TD Cowen - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $137 from $150 at Morgan Stanley - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $135 from $148 at RBC Capital - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $140 from $185 at H.C. Wainwright - TheFly
- 14 days ago - Mirum Pharmaceuticals price target lowered to $137 from $146 at Citizens - TheFly